Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis

Naltrexone is an opioid antagonist used in many different conditions, both licensed and unlicensed. It is used at widely varying doses from 3 to 250 mg. The aim of this review was to extensively evaluate the s…

Leave a Reply

Your email address will not be published.